Literature DB >> 15187492

Mortality in patients with microvascular disease.

David S Marks1, Surrendra Gudapati, L M Prisant, Brooke Weir, Caroline diDonato-Gonzalez, Jennifer L Waller, Jan L Houghton.   

Abstract

Patients with chest pain/ischemic cardiac disease and normal coronary arteriography are thought to have a benign prognosis despite diminished quality of life. Many patients with hypertension fall into this group, at least in the early stage of their disease. Whether abnormalities in coronary flow reserve in these patients are associated with increased morbidity and mortality is unknown. One hundred sixty-eight patients with chest pain/ischemic cardiac disease and normal coronary angiograms who underwent invasive measures of coronary flow reserve were followed longitudinally. Mortality and quality of life were ascertained by query of the national death index and telephone administration of standardized questionnaires. Patient follow-up occurred at a mean of 8.5 years. In the abnormal coronary flow reserve group, 12 deaths (20%) were documented in 60 patients compared with eight out of 108 patients (7%; p=0.016) with normal coronary flow reserve. Coronary flow reserve did not predict impairment in functional health status in long-term follow-up. Thus, invasive measures of coronary flow reserve in patients with chest pain/ischemic cardiac disease and normal coronary angiograms predicted increased mortality. Surviving patients with chest pain/ischemic cardiac disease and normal coronary angiograms have significant morbidity.

Entities:  

Mesh:

Year:  2004        PMID: 15187492      PMCID: PMC8109549          DOI: 10.1111/j.1524-6175.2004.03254.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  33 in total

1.  A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index).

Authors:  M A Hlatky; R E Boineau; M B Higginbotham; K L Lee; D B Mark; R M Califf; F R Cobb; D B Pryor
Journal:  Am J Cardiol       Date:  1989-09-15       Impact factor: 2.778

2.  Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy.

Authors:  S Hamasaki; J Al Suwaidi; S T Higano; K Miyauchi; D R Holmes; A Lerman
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

3.  Measurement of left ventricular wall thickness and mass by echocardiography.

Authors:  B L Troy; J Pombo; C E Rackley
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

4.  Exercise testing in patients with microvascular angina.

Authors:  S E Epstein; R O Cannon; R O Bonow
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

5.  Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion.

Authors:  J Leppo; C A Boucher; R D Okada; J B Newell; H W Strauss; G M Pohost
Journal:  Circulation       Date:  1982-09       Impact factor: 29.690

6.  A negative thallium (+/- dipyridamole) stress test excludes significant obstructive epicardial coronary artery disease in hypertensive patients.

Authors:  L M Prisant; T W von Dohlen; J L Houghton; A A Carr; M J Frank
Journal:  Am J Hypertens       Date:  1992-02       Impact factor: 2.689

7.  Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements.

Authors:  M J Kern; T J Donohue; F V Aguirre; R G Bach; E A Caracciolo; T Wolford; C J Mechem; M S Flynn; B Chaitman
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

8.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

Review 9.  Microvascular angina in systemic hypertension: diagnosis and treatment with enalapril.

Authors:  M M Iriarte; R Caso; N Murga; M López de Argumedo; D Sagastagoitia
Journal:  Am J Cardiol       Date:  1995-11-02       Impact factor: 2.778

10.  The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults.

Authors:  Y Liao; R S Cooper; D L McGee; G A Mensah; J K Ghali
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272

View more
  12 in total

1.  Myocardial Microvascular Physiology in Acute and Chronic Coronary Syndromes, Aortic Stenosis, and Heart Failure.

Authors:  Alf I Larsen; William F Fearon; Todd J Anderson; Nico Pijls
Journal:  J Interv Cardiol       Date:  2022-01-26       Impact factor: 1.776

Review 2.  Coronary microvascular dysfunction in the clinical setting: from mystery to reality.

Authors:  Joerg Herrmann; Juan Carlos Kaski; Amir Lerman
Journal:  Eur Heart J       Date:  2012-08-22       Impact factor: 29.983

3.  Endothelial functions are more severely impaired during active disease period in patients with Behcet's disease.

Authors:  Mustafa Caliskan; Sema Yilmaz; Erkan Yildirim; Hakan Gullu; Dogan Erdogan; Ozgur Ciftci; Gamze Kaynar; Eftal Yucel; Haldun Muderrisoglu
Journal:  Clin Rheumatol       Date:  2006-11-07       Impact factor: 3.650

Review 4.  The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography.

Authors:  Pawel Petkow Dimitrow; Maurizio Galderisi; Fausto Rigo
Journal:  Cardiovasc Ultrasound       Date:  2005-08-04       Impact factor: 2.062

Review 5.  Assessing Coronary Blood Flow Physiology in the Cardiac Catheterisation Laboratory.

Authors:  Sethumadhavan Vijayan; David S Barmby; Ian R Pearson; Andrew G Davies; Stephen B Wheatcroft; Mohan Sivananthan
Journal:  Curr Cardiol Rev       Date:  2017

6.  Association of Isolated Coronary Microvascular Dysfunction With Mortality and Major Adverse Cardiac Events: A Systematic Review and Meta-Analysis of Aggregate Data.

Authors:  Mark A Gdowski; Venkatesh L Murthy; Michelle Doering; Andrea G Monroy-Gonzalez; Riemer Slart; David L Brown
Journal:  J Am Heart Assoc       Date:  2020-04-29       Impact factor: 5.501

7.  Automatic Estimation of Coronary Blood Flow Velocity Step 1 for Developing a Tool to Diagnose Patients With Micro-Vascular Angina Pectoris.

Authors:  Mahdieh Khanmohammadi; Kjersti Engan; Charlotte Sæland; Trygve Eftestøl; Alf I Larsen
Journal:  Front Cardiovasc Med       Date:  2019-01-22

8.  Guidelines for reasonable and appropriate care in the emergency department (GRACE): Recurrent, low-risk chest pain in the emergency department.

Authors:  Paul I Musey; Fernanda Bellolio; Suneel Upadhye; Anna Marie Chang; Deborah B Diercks; Michael Gottlieb; Erik P Hess; Michael C Kontos; Bryn E Mumma; Marc A Probst; John H Stahl; Jason P Stopyra; Jeffrey A Kline; Christopher R Carpenter
Journal:  Acad Emerg Med       Date:  2021-07-06       Impact factor: 5.221

Review 9.  No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.

Authors:  Sanjiv Gupta; Madan Mohan Gupta
Journal:  Indian Heart J       Date:  2016-04-19

10.  High-Sensitivity C-Reactive Protein Is a Predictor of Coronary Microvascular Dysfunction in Patients with Ischemic Heart Disease.

Authors:  David C Tong; Robert Whitbourn; Andrew MacIsaac; Andrew Wilson; Andrew Burns; Sonny Palmer; Jamie Layland
Journal:  Front Cardiovasc Med       Date:  2018-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.